small molecule

PEXEVA

PAROXETINE MESYLATE

Loss of exclusivityloss of exclusivity
CompanySEBELA IRELAND LTD

Drug detail

Brand namePEXEVA
Active ingredientPAROXETINE MESYLATE
StrengthEQ 40MG BASE
Dosage formTABLET
RouteORAL
ModalitySmall molecule
FDA approvalJuly 2003
Marketing statusDISCN

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

PEXEVA patent cliff — loss of exclusivity — | CliffBio